Haematological malignancies data analysis to improve access to new therapies
Haematological malignancies (HM) are a heterogeneous group of diseases with complicated diagnostics and extremely complex treatments. The goal of the EU-funded HARMONY PLUS project is to collect, store and analyse the current HM information to speed up and support the decision-making process for patients’ access to new therapies. The project uses the capabilities of the HARMONY Big Data platform to match the unmet needs by expanding the scope to incorporate myeloproliferative neoplasms including chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia and myelofibrosis as well as lymphoproliferative disorders including Hodgkin’s lymphoma, Waldenström macroglobulinaemia and all rare HMs not covered by the previous HARMONY project.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeIMI2-RIA - Research and Innovation action
28760 Tres Cantos Madrid
69310 Pierre Benite